Wilms' tumor 1-associating protein contributes to psoriasis by promoting keratinocytes proliferation via regulating cyclinA2 and CDK2
Authors:
- 1 November 2020
- journal article
- research article
- Published by Elsevier in International Immunopharmacology
- Vol. 88, 106918
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81872534, 81903223)
This publication has 31 references indexed in Scilit:
- WTAP regulates migration and invasion of cholangiocarcinoma cellsJournal of Gastroenterology, 2013
- Expression and roles of Wilms' tumor 1‐associating protein in glioblastomaCancer Science, 2012
- Skin Inflammation Induced by the Synergistic Action of IL-17A, IL-22, Oncostatin M, IL-1α, and TNF-α Recapitulates Some Features of PsoriasisThe Journal of Immunology, 2010
- Involvement of interleukin-21 in the epidermal hyperplasia of psoriasisNature Medicine, 2009
- A dual role of Cdk2 in DNA damage responseCell Division, 2009
- Wtap is required for differentiation of endoderm and mesoderm in the mouse embryoDevelopmental Dynamics, 2008
- Pathogenesis and clinical features of psoriasisThe Lancet, 2007
- Interleukin-22, a TH17 cytokine, mediates IL-23-induced dermal inflammation and acanthosisNature, 2006
- Wilms' tumor 1-associating protein regulates G 2 /M transition through stabilization of cyclin A2 mRNAProceedings of the National Academy of Sciences, 2006
- Deletion of a common region on the long arm of chromosome 6 in acute lymphoblastic leukaemiaGenes, Chromosomes and Cancer, 1994